1
|
Fiori C, Checcucci E, Stura I, De Cillis S, Amparore D, Piramide F, Piana A, Volpi G, Granato S, Verri P, Sica M, Piscitello S, Ola L, Meziere J, Zamengo D, Cisero E, Della Corte M, Manfredi M, Giuseppe M, Porpiglia F. Identify patients candidate for extended pelvic lymph- node dissection during radical prostatectomy based on target biopsy findings only: Internal validation of novel nomogram. EUR UROL SUPPL 2022. [DOI: 10.1016/s2666-1683(22)02144-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
|
2
|
Checcucci E, Rosati S, De Cillis S, Stura I, Giordano N, Amparore D, Manfredi M, Volpi G, Piana A, Piramide F, Granato S, Meziere J, Zamengo D, Quara’ A, Busacca G, Cisero E, Sterrantino A, Ortenzi M, Gatti C, Pini F, Cristian F, Balestra G, Porpiglia F. Development and validation of a personalized predictive model for fusion prostate biopsy outcomes prediction. EUR UROL SUPPL 2022. [DOI: 10.1016/s2666-1683(22)01289-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
3
|
Checcucci E, Manfredi M, De Cillis S, Amparore D, Piramide F, Piana A, Volpi G, Sica M, Verri P, Granato S, Burgio M, Ola L, Carbonaro B, Zamengo D, Quarà A, Della Corte M, Busacca G, Alessio P, Pecoraro A, Stura I, Migliaretti G, Fiori C, De Luca S, Porpiglia F. Target vs. target plus standard biopsy in naïve patients: Results of a prospective randomized controlled trial. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00538-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
4
|
Fiori C, Checcucci E, De Cillis S, Amparore D, Volpi G, Piramide F, Sica M, Piscitello S, Burgio M, Carbonaro B, Zamengo D, Cossu M, Manfredi M, Bollito E, Stura I, Migliaretti G, Porpiglia F. Target only vs target plus standard biopsy in naïve patients: analysis of detection rate and comparison with radical prostatectomy specimens. EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)00907-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
5
|
Sobrero S, Sandri A, Gagliasso M, Errico L, Novello S, Migliaretti G, Stura I, Leo F. P42.01 Tumor Size is an Independent Prognostic Factor after Pulmonary Metastasectomy. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.08.460] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
6
|
Fiori C, Checcucci E, Stura I, Amparore D, De Cillis S, Pecoraro A, Piana A, Piramide F, Volpi G, Verri P, Granato S, De Luca S, Di Dio M, Agostino D, Gned D, Manfredi M, Giuseppe M, Porpiglia F. A Novel nomogram including mpMRI and target biopsy to guide the indication to extended pelvic lymph-node dissection during radical prostatectomy. EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)00974-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
7
|
Checcucci E, Fiori C, Stura I, Amparore D, De Cillis S, Pecoraro A, Alessio P, Piana A, Piramide F, Volpi G, Verri P, Granato S, Carbonaro B, Zamengo D, De Pascale A, Gned D, Manfredi M, Migliaretti G, Porpiglia F. Novel nomogram to identify patients candidate for extended pelvic lymph-node dissection during radical prostatectomy based on target biopsy findings only. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)01584-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
8
|
Capelletto E, Morabito A, Grossi F, Costanzo FD, Osman G, Chiari R, Bordi P, Scotti V, Romano G, Delmonte A, Galetta D, Ciuffreda L, Manzo A, Genova C, Mazzoni F, Morelli A, Critelli R, Stura I, Migliaretti G, Novello S. Post progression survival for patients treated with docetaxel/nintedanib in the SENECA trial. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz260.090] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
9
|
Capelletto E, Osman G, Morabito A, Chiari R, Grossi F, Tiseo M, Di Costanzo F, Delmonte A, Romano G, Misino A, Scotti V, Gregorc V, Pisconti S, Bonomi M, Del Conte A, Ciuffreda L, Colantonio I, Bria E, Ricciardi S, Manzo A, Metro G, Morelli A, Critelli R, Stura I, Migliaretti G, Novello S. P2.04-84 NSCLC Survival Expectancy for Patients Treated with Docetaxel/Nintedanib in the SENECA Trial and Previous Immunotherapy. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.1589] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
10
|
Migliaretti G, Ame C, Ciullo S, Fontana E, Stura I, Nano E, Laino F, Isoardo G. Metabolic and psychological effects of short-term increased consumption of less-processed foods in daily diets: A Pilot Study. Diabetes Metab 2019; 46:66-69. [PMID: 31325499 DOI: 10.1016/j.diabet.2019.07.002] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/04/2019] [Revised: 06/16/2019] [Accepted: 07/07/2019] [Indexed: 12/30/2022]
Abstract
AIM This study evaluated whether the consumption of locally produced food without additives might have a positive effect on known risk factors for non-communicable diseases (NCDs) such as hypertension, and levels of fasting glucose and visceral adipose tissue (VAT). Attention was focused on various types of cheese, sausages, fresh pasta, pastries, biscuits and chocolate without additives to make them palatable and durable for transport. METHODS Healthy volunteers were randomized to purchase the foods under study from either local producers not using additives (group 1) or supermarkets (group 2). At baseline and after 6 months, both groups underwent evaluation for weight, blood pressure, VAT, serum sodium, potassium, fasting glucose, insulin, C-peptide and creatinine levels, and also the State-Trait Anxiety Inventory (STAI) and Beck Depression Inventory (BDI-II) by examiners blinded to group allocation. At baseline, the state part of the STAI and Wechsler Adult Intelligence Scale IV were also performed, and body mass index, HOMA index and estimated glomerular filtration rate calculated. RESULTS Data for 159 subjects (89 in group 1, 70 in group 2) were analyzed. Baseline evaluations did not differ between groups. At 6 months, HOMA scores and fasting glucose levels were lower in group 1 than in group 2 (P<0.01). Also, in group 1, VAT (P=0.006), systolic blood pressure (P=0.001) and BDI-II score (P=0.0005) were decreased, whereas serum fasting glucose (P=0.04) and C-peptide (P=0.03) levels, and diastolic blood pressure (P=0.02), were increased in group 2. CONCLUSION Consumption of the locally produced food under study improved some of the major risk factors for NCDs after 6 months.
Collapse
Affiliation(s)
- G Migliaretti
- Department of Public Health and Paediatric Sciences, University of Turin, Via Santena 5 bis, I-10126 Torino, Italy.
| | - C Ame
- Medical Team, Turin, Italy
| | - S Ciullo
- Department of Psychology, University of Turin, Turin, Italy
| | - E Fontana
- Department of Psychology, University of Turin, Turin, Italy
| | - I Stura
- Department of Public Health and Paediatric Sciences, University of Turin, Via Santena 5 bis, I-10126 Torino, Italy
| | - E Nano
- Graduate Institute Geneva, Geneva, Switzerland
| | - F Laino
- Palliative Care and Pain Therapy Unit and, Hospital Città della Salute e della Scienza, Turin, Italy
| | - G Isoardo
- Palliative Care and Pain Therapy Unit and, Hospital Città della Salute e della Scienza, Turin, Italy
| |
Collapse
|
11
|
Bessone F, Argenziano M, Grillo G, Ferrara B, Pizzimenti S, Barrera G, Cravotto G, Guiot C, Stura I, Cavalli R, Dianzani C. Low-dose curcuminoid-loaded in dextran nanobubbles can prevent metastatic spreading in prostate cancer cells. Nanotechnology 2019; 30:214004. [PMID: 30654342 DOI: 10.1088/1361-6528/aaff96] [Citation(s) in RCA: 17] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
Preventing recurrences and metastasis of prostate cancer after prostatectomy by administering adjuvant therapies is quite a controversial issue. In addition to effectiveness, absence of side effects and long term toxicity are mandatory. Curcuminoids (Curc) extracted with innovative techniques and effectively loaded by polymeric nanobubbles (Curc-NBs) satisfy such requirements. Curc-NBs showed stable over 30 d, were effectively internalized by tumor cells and were able to slowly release Curc in a sustained way. Significant biological effects were detected in PC-3 and DU-145 cell lines where Curc-NBs were able to inhibit adhesion and migration, to promote cell apoptosis and to affect cell viability and colony-forming capacity in a dose-dependent manner. Since the favourable effects are already detectable at very low doses, which can be reached at a clinical level, the actual drug concentration can be visualized and monitored by US or MRI, Curc-NBs can be proposed as an effective adjuvant theranostic tool.
Collapse
Affiliation(s)
- F Bessone
- Department of Drug Science & Technology, University of Torino, Torino, Italy
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
12
|
Morelli A, Migliorino M, Morabito A, Chiari R, Grossi F, Bordi P, Di Costanzo F, Delmonte A, Romano G, Misino A, Scotti V, Gregorc V, Pisconti S, Ceresoli G, Del Conte A, Colantonio I, Ciuffreda L, Capelletto E, Stura I, Novello S. Safety of nintedanib plus docetaxel in advanced non-squamous NSCLC (nsNSCLC) patients: The preliminary results of the SENECA (second-line nintedanib in non-small cell lung cancer) trial. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy292.026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
13
|
Migliaretti G, Ditaranto S, Guiot C, Vannelli S, Matarazzo P, Cappello N, Stura I, Cavallo F. Long-term response to recombinant human growth hormone treatment: a new predictive mathematical method. J Endocrinol Invest 2018; 41:839-848. [PMID: 29318462 DOI: 10.1007/s40618-017-0816-6] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/28/2017] [Accepted: 12/24/2017] [Indexed: 10/18/2022]
Abstract
INTRODUCTION Recombinant GH has been offered to GH-deficient (GHD) subjects for more than 30 years, in order to improve height and growth velocity in children and to enhance metabolic effects in adults. AIM The aim of our work is to describe the long-term effect of rhGH treatment in GHD pediatric patients, suggesting a growth prediction model. MATERIAL AND METHODS A homogeneous database is defined for diagnosis and treatment modalities, based on GHD patients afferent to Hospital Regina Margherita in Turin (Italy). In this study, 232 GHD patients are selected (204 idiopathic GHD and 28 organic GHD). Each measure is shown in terms of mean with relative standard deviations (SD) and 95% confidence interval (95% CI). To estimate the final height of each patient on the basis of few measures, a mathematical growth prediction model [based on Gompertzian function and a mixed method based on the radial basis functions (RBFs) and the particle swarm optimization (PSO) models] was performed. RESULTS The results seem to highlight the benefits of an early start of treatment, further confirming what is suggested by the literature. Generally, the RBF-PSO method shows a good reliability in the prediction of the final height. Indeed, RMSE is always lower than 4, i.e., in average the forecast will differ at most of 4 cm to the real value. CONCLUSIONS In conclusion, the large and accurate database of Italian GHD patients allowed us to assess the rhGH treatment efficacy and compare the results with those obtained in other Countries. Moreover, we proposed and validated a new mathematical model forecasting the expected final height after therapy which was validated on our cohort.
Collapse
Affiliation(s)
- G Migliaretti
- Depth of Public Health and Pediatric Sciences, University of Turin, Turin, Italy.
| | - S Ditaranto
- Depth of Public Health and Pediatric Sciences, University of Turin, Turin, Italy
| | - C Guiot
- Depth of Neurosciences, University of Turin, Turin, Italy
| | - S Vannelli
- Pediatric Endocrinology, Regina Margherita Children Hospital, University of Turin, Turin, Italy
| | - P Matarazzo
- Pediatric Endocrinology, Regina Margherita Children Hospital, University of Turin, Turin, Italy
| | - N Cappello
- Depth of Public Health and Pediatric Sciences, University of Turin, Turin, Italy
| | - I Stura
- Depth of Public Health and Pediatric Sciences, University of Turin, Turin, Italy
| | - F Cavallo
- Depth of Public Health and Pediatric Sciences, University of Turin, Turin, Italy
| |
Collapse
|